Literature DB >> 12047017

Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles.

Nancy H Covell1, Carlos T Jackson, Arthur C Evans, Susan M Essock.   

Abstract

We characterized prescribing in Connecticut's State public mental health system to assess the feasibility of implementing an evidence-based medication algorithm. Medication records for a random sample of outpatients with diagnoses of schizophrenia spectrum disorders showed prescribing patterns similar to the entire United States. The base rate of changing antipsychotic medications was moderate. Over half of patients received decanoate medications, polypharmacy was nontrivial, and there was variability in prescribing patterns across physicians. Caucasian patients were more likely to receive an atypical antipsychotic and less likely to have a decanoate medication, and Latino patients were less likely to change medications. Because the base rate of changing medications was moderate and a considerable proportion of patients were prescribed newer antipsychotic medications, introducing a research-derived medication algorithm with newer atypical antipsychotics as first line agents may fit well with current practice. Further, implementing such an algorithm may reduce racial and ethnic disparities in prescribing patterns.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12047017     DOI: 10.1093/oxfordjournals.schbul.a006920

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  39 in total

Review 1.  Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.

Authors:  Juan A Gallego; John Bonetti; Jianping Zhang; John M Kane; Christoph U Correll
Journal:  Schizophr Res       Date:  2012-04-24       Impact factor: 4.939

Review 2.  Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis.

Authors:  Joseph H Puyat; Jamie R Daw; Colleen M Cunningham; Michael R Law; Sabrina T Wong; Devon L Greyson; Steven G Morgan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-08-14       Impact factor: 4.328

Review 3.  A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy.

Authors:  William G Honer; Ric M Procyshyn; Eric Y H Chen; G William MacEwan; Alasdair M Barr
Journal:  J Psychiatry Neurosci       Date:  2009-11       Impact factor: 6.186

4.  Antipsychotic combinations for schizophrenia.

Authors:  Nicola Maayan; Karla Soares-Weiser; Jun Xia; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2011

Review 5.  The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

Authors:  Sofia Brissos; Miguel Ruiz Veguilla; David Taylor; Vicent Balanzá-Martinez
Journal:  Ther Adv Psychopharmacol       Date:  2014-10

6.  The effect of race-ethnicity on the comparative effectiveness of clozapine among Medicaid beneficiaries.

Authors:  Marcela Horvitz-Lennon; Julie M Donohue; Judith R Lave; Margarita Alegría; Sharon-Lise T Normand
Journal:  Psychiatr Serv       Date:  2013-03-01       Impact factor: 3.084

7.  Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study.

Authors:  James A Kaye; Brian D Bradbury; Hershel Jick
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

8.  Racial and ethnic disparities in the treatment of a Medicaid population with schizophrenia.

Authors:  Marcela Horvitz-Lennon; Thomas G McGuire; Margarita Alegria; Richard G Frank
Journal:  Health Serv Res       Date:  2009-09-24       Impact factor: 3.402

9.  Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting.

Authors:  Taishiro Kishimoto; Sohag Sanghani; Mark J Russ; Akeem N Marsh; Joshua Morris; Suparna Basu; Majnu John; John M Kane
Journal:  Int Clin Psychopharmacol       Date:  2017-05       Impact factor: 1.659

10.  Prescription of psychotropic drugs to patients with schizophrenia: an Italian national survey.

Authors:  Lorenza Magliano; Andrea Fiorillo; Manuela Guarneri; Cecilia Marasco; Corrado De Rosa; Claudio Malangone; Mario Maj
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.